Literature DB >> 30374592

[Combination immunotherapy for patients with brain metastases of malignant melanoma: de-escalation only under controlled conditions with frequent imaging].

Carsten Nieder1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30374592     DOI： 10.1007/s00066-018-1392-1

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN： 0179-7158            Impact factor:   3.621


× No keyword cloud information.
  5 in total

1.  Omitting radiosurgery in melanoma brain metastases: a drastic and dangerous de-escalation.

Authors:  Tim J Kruser; Vinai Gondi; Paul W Sperduto; Paul D Brown; Minesh P Mehta
Journal:  Lancet Oncol       Date:  2018-08       Impact factor: 41.316

2.  Combined Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain.

Authors:  Hussein A Tawbi; Peter A Forsyth; Alain Algazi; Omid Hamid; F Stephen Hodi; Stergios J Moschos; Nikhil I Khushalani; Karl Lewis; Christopher D Lao; Michael A Postow; Michael B Atkins; Marc S Ernstoff; David A Reardon; Igor Puzanov; Ragini R Kudchadkar; Reena P Thomas; Ahmad Tarhini; Anna C Pavlick; Joel Jiang; Alexandre Avila; Sheena Demelo; Kim Margolin
Journal:  N Engl J Med       Date:  2018-08-23       Impact factor: 91.245

3.  Estimating Survival in Melanoma Patients With Brain Metastases: An Update of the Graded Prognostic Assessment for Melanoma Using Molecular Markers (Melanoma-molGPA).

Authors:  Paul W Sperduto; Wen Jiang; Paul D Brown; Steve Braunstein; Penny Sneed; Daniel A Wattson; Helen A Shih; Ananta Bangdiwala; Ryan Shanley; Natalie A Lockney; Kathryn Beal; Emil Lou; Thomas Amatruda; William A Sperduto; John P Kirkpatrick; Norman Yeh; Laurie E Gaspar; Jason K Molitoris; Laura Masucci; David Roberge; James Yu; Veronica Chiang; Minesh Mehta
Journal:  Int J Radiat Oncol Biol Phys       Date:  2017-11-15       Impact factor: 7.038

4.  Immune checkpoint inhibitors and radiosurgery for newly diagnosed melanoma brain metastases.

Authors:  Tyler P Robin; Robert E Breeze; Derek E Smith; Chad G Rusthoven; Karl D Lewis; Rene Gonzalez; Amanda Brill; Robin Saiki; Kelly Stuhr; Laurie E Gaspar; Sana D Karam; David Raben; Brian D Kavanagh; Sameer K Nath; Arthur K Liu
Journal:  J Neurooncol       Date:  2018-06-16       Impact factor: 4.130

5.  Combination nivolumab and ipilimumab or nivolumab alone in melanoma brain metastases: a multicentre randomised phase 2 study.

Authors:  Georgina V Long; Victoria Atkinson; Serigne Lo; Shahneen Sandhu; Alexander D Guminski; Michael P Brown; James S Wilmott; Jarem Edwards; Maria Gonzalez; Richard A Scolyer; Alexander M Menzies; Grant A McArthur
Journal:  Lancet Oncol       Date:  2018-03-27       Impact factor: 41.316
  5 in total
  1 in total

1.  Tumour-Infiltrating Inflammatory Cells in Early Breast Cancer: An Underrated Prognostic and Predictive Factor?

Authors:  Sören Schnellhardt; Ramona Erber; Maike Büttner-Herold; Marie-Charlotte Rosahl; Oliver J Ott; Vratislav Strnad; Matthias W Beckmann; Lillian King; Arndt Hartmann; Rainer Fietkau; Luitpold Distel
Journal:  Int J Mol Sci       Date:  2020-11-03       Impact factor: 5.923
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.